Hayley C. Gorton, PhD; Roger T. Webb, PhD; Matthew J. Carr, PhD; et al.
free access
JAMA Neurol. 2018;75(8):929-938. doi:10.1001/jamaneurol.2018.0333
This population-based cohort study uses 2 large electronic primary care data sets linked to hospitalization and mortality records in England and Wales to estimate cause-specific unnatural mortality risks in people with epilepsy and to identify the medication types involved in poisoning deaths.
Inga Peter, PhD; Marla Dubinsky, MD; Susan Bressman, MD; et al.
free access
JAMA Neurol. 2018;75(8):939-946. doi:10.1001/jamaneurol.2018.0605
This cohort study uses 2 large administrative claims databases to examine the incidence of Parkinson disease among patients with inflammatory bowel disease and to assess whether exposure to antitumor necrosis factor therapy among these patients mitigates Parkinson disease risk.
Michael R. Wilson, MD, MAS; Brian D. O’Donovan, MS; Jeffrey M. Gelfand, MD, MAS; et al.
open access
JAMA Neurol. 2018;75(8):947-955. doi:10.1001/jamaneurol.2018.0463
This case series of 7 participants assesses whether metagenomic next-generation sequencing of cerebrospinal fluid can be leveraged to aid in determining diagnoses among patients with subacute or chronic meningitis.
Mollie McDermott, MD, MS; Douglas J. Gelb, MD, PhD; Kelsey Wilson, BS; et al.
free access
JAMA Neurol. 2018;75(8):956-961. doi:10.1001/jamaneurol.2018.0275
This cross-sectional study investigates the potential sex differences at each faculty rank in top-ranked US academic neurology programs by comparing the number of male vs female neurologists and their level of academic productivity quantitated by publication rates and scholarly activities.
Page B. Pennell, MD; Jacqueline A. French, MD; Cynthia L. Harden, MD; et al.
free access
JAMA Neurol. 2018;75(8):962-969. doi:10.1001/jamaneurol.2018.0646
This multicenter cohort study aims to determine if women with epilepsy without a prior diagnosis of infertility or related disorders are as likely to achieve pregnancy within 12 months as their peers without epilepsy.
Rosebud O. Roberts, MB, ChB, MS; Jeremiah A. Aakre, MPH; Walter K. Kremers, PhD; et al.
free access
JAMA Neurol. 2018;75(8):970-979. doi:10.1001/jamaneurol.2018.0629
This population-based study assesses the prevalence and outcomes of amyloid positivity in a large population of individuals who are cognitively unimpaired or have mild cognitive impairment.
Tejaswi Kandula, MBBS; Michelle Anne Farrar, MBBS, PhD; Richard J. Cohn, MBBCh; et al.
free access
JAMA Neurol. 2018;75(8):980-988. doi:10.1001/jamaneurol.2018.0963
This cross-sectional study comprehensively assesses chemotherapy-induced peripheral neuropathy in childhood cancer survivors to define disease burden and functional effect and aims to inform screening recommendations.
Timothy J. Hohman, PhD; Logan Dumitrescu, PhD; Lisa L. Barnes, PhD; et al.
free access
JAMA Neurol. 2018;75(8):989-998. doi:10.1001/jamaneurol.2018.0821
This multicohort study evaluates sex differences in the association between APOE and markers of Alzheimer disease neuropathology measured in cerebrospinal fluid during life or in brain tissue at autopsy.
Hee Jin Kim, MD, PhD; Seongbeom Park, MS; Hanna Cho, MD, PhD; et al.
free access
JAMA Neurol. 2018;75(8):999-1007. doi:10.1001/jamaneurol.2018.0975
This cross-sectional study investigates the extent and the role of tau in patients with subcortical vascular cognitive impairment using 18F-AV1451, which is a new ligand to detect neurofibrillary tangles in vivo.